scholarly journals Research Progress on Refractory Hypertension in Traditional Chinese Medicine

2021 ◽  
Vol 5 (4) ◽  
pp. 121-124
Author(s):  
Nana Zhou ◽  
Jinyu Chen ◽  
Ru Han ◽  
Yuanlin Lei

At present, the mortality rate and disability rate caused by cardiovascular and cerebrovascular diseases are very high in China. Individuals with refractory hypertension are at a greater risk of developing chronic kidney disease, heart failure, stroke and myocardial infarction. Therefore, how to effectively control blood pressure and identify the cause of refractory hypertension is a problem that medical workers need to solve, and it is also the key to prevent cardiovascular disease. In recent years, the government actively supports the development of traditional Chinese medicine. Since the curative effect of traditional Chinese medicine is recognized by the public, the prospect of traditional Chinese medicine in the prevention and treatment of refractory hypertension is considerable, and it is expected to become the main key research direction in the future.

2022 ◽  
Vol 50 (1) ◽  
pp. 9-16
Author(s):  
Jia-ying Yuan ◽  
Zhi-ying Tong ◽  
Yu-chao Dong ◽  
Jia-yi Zhao ◽  
Yan Shang

Bronchial asthma is a common chronic airway disease, and long-term management of asthma is the focus and difficulty of clinical treatment. Glucocorticoids are often used as the first choice for the treatment of asthma. However, the occurrence of hormone dependence, hormone resistance, local and systemic adverse reactions caused by hormone application also brings problems for the treatment of asthma. Finding safe and effective new therapeutic drugs is an important research direction at present. Icariin is the effective ingredient of traditional Chinese medicine Epimedium. It has various biological activities such as anti-inflammatory, anti-oxidative stress, and immune regulation. It has high safety and has a wide range of clinical applications. Icariin has the characteristics of multi-target intervention in the treatment of asthma. This article reviews recent studies in order to provide new research directions for further therapeutic drug development.


2021 ◽  
Vol 5 (4) ◽  
pp. 97-99
Author(s):  
Ningjing Wu ◽  
Rong Li ◽  
Zongliang Song

By collecting and sorting out the literature and journals on the clinical use of Chinese medicine in the treatment of diabetic nephropathy in recent years, it is concluded that Chinese medicine is effective in the treatment of DKD. Chinese medicine therapy has a unique role in the treatment of diabetic nephropathy. How to correct syndrome differentiation and treatment? Improving clinical effects is the research direction that all medical staff will work together in the future.


2020 ◽  
Vol 127 ◽  
pp. 110136 ◽  
Author(s):  
Yubao Lu ◽  
Jingjing Yang ◽  
Xuexi Wang ◽  
Zhanjun Ma ◽  
Sheng Li ◽  
...  

2021 ◽  
Vol 5 (4) ◽  
pp. 144-147
Author(s):  
Dan Zhang ◽  
Jing Cai ◽  
Xiaoping Cui ◽  
Xinchun Xiao

In recent years, the frequency of clinical occurrence of abnormal uterine bleeding in adolescence has gradually increased. In order to fully understand the research progress in the treatment of abnormal uterine bleeding in adolescence, various studies and clinical experience have been reviewed by consulting related literature reports. The results found that currently Western medicine mainly uses hormone drugs in clinical treatment, but there are risks such as more clinical adverse reactions and higher recurrence rate; traditional Chinese medicine (TCM) treatment has achieved satisfactory results, but the advantages of sudden collapse and hemostasis are not obvious. Combined TCM and Western medicine treatment, it can learn from each other and has become a research hotspot in recent years, which is worthy of an in-depth discussion.


2020 ◽  
Vol 121 ◽  
pp. 109565 ◽  
Author(s):  
Jingkang Wang ◽  
Quantao Ma ◽  
Yaqi Li ◽  
Pengfei Li ◽  
Min Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document